U.S. Banks Stock News

If you are wondering whether Biogen's current share price reflects its true worth, you are not alone. Many investors are asking whether the stock still offers value after its recent moves. The stock last closed at US$179.90, with a 1 year return of 49.3% but also shorter term moves of a 2.1% decline over 7 days, a 4.4% decline over 30 days, and a modest 1.2% gain year to date. These shifts can change how the market views both its growth potential and risk. Recent news flow around Biogen has...

Wondering whether PTC at around US$144 per share offers real value or just noise? This article walks through what the current price may be implying about the business. The stock is up 1.3% over the last 7 days, even though it shows a 11.7% decline over 30 days and a 15.2% decline year to date, with a 3.3% decline over the past year and a 14.2% return over three years. These mixed returns put extra focus on what has been moving sentiment around PTC recently, as investors react to new...

Wondering whether Equifax at US$184.38 is starting to look interesting on price, or if there is a better entry point? This article walks through what the current market value really reflects. The stock has recently shown mixed performance, with a 2.6% move over the past week, a 9.9% decline over 30 days, and returns of 13.9% lower year to date and 17.1% lower over the past year. These moves have kept Equifax in focus for investors who follow business services names and are weighing how...

Virgin Galactic Holdings recently filed a US$1.35 million shelf registration for 555,000 shares tied to its employee stock plan and reported fourth-quarter 2025 sales of US$312,000 alongside a net loss of US$62.72 million. At the same time, the company has reopened US$750,000-per-seat ticket sales and advanced its Delta-class spacecraft toward testing, highlighting a push to align capital, talent and product readiness ahead of a planned return to commercial service. We’ll now examine how the...

Mid-America Apartment Communities (MAA) is back in focus as analysts update their views, the REIT prepares to report upcoming earnings, and insiders execute planned share sales alongside a recently confirmed quarterly dividend. See our latest analysis for Mid-America Apartment Communities. The recent 1-day share price return of 1.44% and 7-day gain of 2.89% to US$126.09 sit against a weaker backdrop, with a 30-day share price return of 4.58% and a 1-year total shareholder return of 16.66%...

Why Stepan Stock Is Back on Investors’ Radar Stepan (SCL) has drawn fresh attention after its recent share move, with the stock closing at $51.55 and short term returns over the past week and month turning positive. See our latest analysis for Stepan. The recent 1 month share price return of 7.44% and year to date share price return of 9.31% contrast with a 5 year total shareholder return decline of 55.97%, which suggests momentum has only recently started to improve. If Stepan’s rebound has...

Kura Sushi USA (KRUS) opened Q2 2026 with revenue of US$80.0 million, a basic EPS loss of US$0.14, and net income loss of US$1.7 million, setting the tone for another quarter where top line growth is front and center while profitability remains under pressure. The company has reported quarterly revenue increasing from US$64.9 million in Q2 2025 to US$80.0 million in Q2 2026, while basic EPS moved from a loss of US$0.31 to a loss of US$0.14 over the same period, alongside a trailing twelve...

BeOne Medicines recently received FDA Orphan Drug Designation for its lead hepatocellular carcinoma candidate, while research firms initiated and adjusted coverage highlighting its broad oncology program and flagship therapy Brukinsa. This combination of regulatory recognition and shifting analyst views underscores how expectations for BeOne’s pipeline and commercialization efforts are being actively reassessed by the market. Next, we’ll examine how the new FDA Orphan Drug Designation could...

If you are wondering whether Citigroup's current share price still offers value, the recent share performance gives you plenty to think about. The stock last closed at US$123.49, with returns of 7.1% over 7 days, 15.9% over 30 days, 4.0% year to date and 97.5% over 1 year. The 3 year and 5 year returns sit at 192.2% and 101.8% respectively. These moves have kept Citigroup firmly on the radar for investors watching large U.S. banks, as sentiment around the sector and interest rate...

AI runs on real world hardware, and right now that physical backbone is where a lot of the attention is going. While energy prices, interest rate expectations, and geopolitical tensions are keeping many sectors on edge, the companies building data centers, power connections, and cooling systems are dealing in tangible demand. The AI Infrastructure Stocks screener focuses on those providers that are turning sales into cash flow, instead of just selling a story. In this article, you will see 3...

In recent months, hedge funds such as Duquesne Capital have been increasing their positions in BBB Foods Inc. (NYSE:TBBB), while the company has expanded its Mexican grocery footprint by opening 574 net new stores during 2025. This combination of rising institutional ownership and rapid store rollout highlights how investors are focusing on BBB Foods’ potential to win customers from traditional mom-and-pop retailers through scale and private-label offerings. Next, we will examine how BBB...

Cousins Properties has closed a new five-year, US$1.20 billion unsecured credit facility, expanding borrowing capacity, lowering spreads over SOFR, and extending term loan flexibility while keeping financial covenants largely unchanged. Separately, Cousins announced a long-term lease with Oracle for 116,000 square feet at its Neuhoff mixed-use project in Nashville, further supporting occupancy across the office-led development, which is already substantially leased in its office and...

NetApp (NasdaqGS:NTAP) and Nutanix have announced a new alliance to combine NetApp's Intelligent Data Infrastructure with the Nutanix Cloud Platform and hypervisor. The joint offering is designed for hybrid and multicloud environments, with capabilities for streamlined migration, simplified operations, VM level management, and built in cyber resilience. NetApp and Nutanix also plan deeper integration over time to support customers that are pursuing AI related use cases. For investors...

Markets are being pulled in different directions by energy prices, interest rate expectations, and shifting inflation trends, and that can make it harder to know where to focus. One clear anchor is leadership that is deeply invested in its own business. Founder led companies, where leaders typically hold meaningful stakes and think in decades rather than quarters, can offer a different quality of commitment. This article looks at our Top Founder Led Companies screener and highlights three...

In recent commentary, Herc Holdings (NYSE:HRI) was reported to have seen costs rise faster than revenue over the past five years, contributing to a 7.3 percentage point decline in operating margin and a net-debt-to-EBITDA ratio of 5 times that may limit its access to new capital. This combination of margin compression and elevated leverage raises questions about Herc’s financial flexibility and capacity to fund growth without resorting to potentially dilutive equity issuance. Next, we will...

Nurix Therapeutics (NRIX) opened 2026 with Q1 revenue of US$6.3 million and a basic EPS loss of US$0.79, while trailing twelve month figures show revenue of US$71.8 million against a basic EPS loss of US$3.17, framing a business that is still firmly in investment mode. Over the past year, the company has seen quarterly revenue range from US$6.3 million to US$44.1 million and basic EPS move between a loss of US$0.52 and a loss of US$1.03, giving investors a clear view of how top line progress...

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis. The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis. Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model. Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...

BOK Financial (NasdaqGS:BOKF) has promoted Scott Andrews to lead its Specialized Industries Banking group. The appointment follows the planned retirement of Executive Vice President Brad Vincent. The transition affects key lines of business including commercial real estate, energy, and healthcare banking. BOK Financial’s Specialized Industries Banking unit sits at the core of its commercial franchise, with exposure to sectors that tend to be closely watched by lenders and regulators. Areas...

Aehr Test Systems (AEHR) has released its Q3 2026 numbers, reporting revenue of US$10.3 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$3.2 million loss. The company has seen quarterly revenue move between US$13.5 million and US$18.3 million since Q2 2025, while basic EPS has ranged from a profit of US$0.78 per share on a trailing twelve month basis in 2025 to a loss of US$0.38 per share over the most recent twelve month window. This keeps the focus...

If you are wondering whether PagSeguro Digital's current share price truly reflects its underlying worth, this article walks through the key signals you can use to judge that. The stock recently closed at US$10.76, with returns of 2.2% over the last 7 days, 7.8% over 30 days, 11.3% year to date, 35.4% over 1 year, 31.3% over 3 years and a 75.3% decline over 5 years. Recent coverage has focused on PagSeguro Digital's position within diversified financials and how changing views on digital...

CVB Financial received final regulatory approval for its merger with Heritage Commerce. The companies now have clearance to close the transaction, which is expected to happen imminently. The approval moves the combination from planning to full integration for customers, employees, and shareholders. For investors tracking CVB Financial, ticker NasdaqGS:CVBF, the timing of this approval comes with the stock at $20.3 and a value score of 4. Over the past year the shares have returned 20.8%,...

Royalty Pharma (RPRX) is back in focus after announcing a US$500 million R&D co funding agreement with Johnson & Johnson to advance JNJ-4804, an investigational autoimmune therapy targeting IL-23 and TNF pathways. See our latest analysis for Royalty Pharma. The J&J co funding news lands on top of an already strong run, with Royalty Pharma’s 90 day share price return of 18.98% and 1 year total shareholder return of 51.96% suggesting momentum has been building. If this kind of deal making has...

Event driven snapshot of Gibraltar Industries With no single headline event setting the tone, Gibraltar Industries (ROCK) draws attention through its recent trading performance, mixed short term and multi month returns, and value focused metrics that many investors are reassessing. See our latest analysis for Gibraltar Industries. The recent 5.35% 1-day share price return and 2.50% 7-day share price return contrast with a 90-day share price return decline of 21.39% and a 1-year total...

Event context and recent price action HeartFlow (HTFL) has attracted fresh attention after a recent uptick in its share price, building on a 0.8% gain over the past day and a 10.5% move across the past week. That short term strength sits alongside a 16.8% rise over the past month, set against a 19.1% decline across the past 3 months and a 6.5% negative return year to date. Together, these figures give investors a mixed recent picture. See our latest analysis for HeartFlow. Putting that into...